Metastatic melanoma of unknown primary: an unusual dermatologic presentation

Metastatic melanoma without an identifiable primary lesion presents a unique diagnostic challenge and raises consideration of immune-mediated regression or non-cutaneous tumour origin. We describe the case of a man in his 80s diagnosed with metastatic melanoma, for whom a thorough skin examination and staging workup revealed no definitive primary lesion. Dermatologic evaluation revealed vitiligo-like depigmentation and a grey macule with clinical features suggestive of regression. While a definitive primary site could not be established, the constellation of clinical and dermatologic findings raises consideration of melanoma-associated depigmentation, an immune phenomenon in which both melanocytes and melanoma cells are targeted. This case highlights how immune-mediated mechanisms may obscure the detection of a primary lesion. Recognition of this pattern may aid in evaluating atypical presentations and contribute to the broader understanding of immune involvement in melanoma progression.

Authors

Institutions

Publication Details

Journal
BMJ Case Reports
Published
2026-02-01
DOI
https://doi.org/10.1136/bcr-2025-269052
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metastatic melanoma of unknown primary: an unusual dermatologic presentation

Elizabeth Boswell, Rene Chen, Kali Morrissette, Michelle Pavlis et al.
BMJ Case Reports
Cutaneous Melanoma Detection and Management
article

Metastatic melanoma of unknown primary: an unusual dermatologic presentation

Elizabeth Boswell, Rene Chen, Kali Morrissette, Michelle Pavlis, Sarah Cater
article en

Abstract

Metastatic melanoma without an identifiable primary lesion presents a unique diagnostic challenge and raises consideration of immune-mediated regression or non-cutaneous tumour origin. We describe the case of a man in his 80s diagnosed with metastatic melanoma, for whom a thorough skin examination and staging workup revealed no definitive primary lesion. Dermatologic evaluation revealed vitiligo-like depigmentation and a grey macule with clinical features suggestive of regression. While a definitive primary site could not be established, the constellation of clinical and dermatologic findings raises consideration of melanoma-associated depigmentation, an immune phenomenon in which both melanocytes and melanoma cells are targeted. This case highlights how immune-mediated mechanisms may obscure the detection of a primary lesion. Recognition of this pattern may aid in evaluating atypical presentations and contribute to the broader understanding of immune involvement in melanoma progression.

BMJ Case ReportsVol. 19(2)
Duke University (US), Duke Medical Center (US), Durham VA Medical Center (US), Duke University Hospital (US)
Good health and well-being
Openalex Percentile: Top 55%
Cutaneous Melanoma Detection and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Metastatic melanoma of unknown primary: an unusual dermatologic presentation — Elizabeth Boswell, Rene Chen, et al. · BMJ Case Reports (2026) | TGRS Research Map | TGRS